Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

3(60.0%)

Phase 3

1(20.0%)

N/A

1(20.0%)

5Total

Phase 4(3)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06395883Recruiting

Dynamics in Bone Turnover Markers During and After Short-term Glucocorticoid Treatment in Patients With an Inflammatory Joint Disease

Role: collaborator

NCT06498856Not Yet Recruiting

Saline Infusion Test in Hyponatremia

Role: collaborator

NCT04303026Phase 3Unknown

The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip

Role: collaborator

NCT01482689Not ApplicableCompleted

Bioavailability of Vitamin D in Cod Liver Oil and Multivitamin Tablets in Healthy Subjects in Norway

Role: collaborator

NCT00914901Phase 4Unknown

Concentrations of Salmeterol in Blood and Urine

Role: collaborator

NCT00914654Phase 4Unknown

Concentrations of Formoterol in Blood and Urine

Role: collaborator

NCT00914797Phase 4Unknown

Terbutaline Concentrations in Blood and Urine

Role: collaborator

NCT00277121Unknown

Genetic Origin of Lipid Disorders

Role: collaborator

All 8 trials loaded